111 Capital’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
111 Capital's GH Position: Q3 2026 in Review
111 Capital sold out of Guardant Health (GH) in Q3 2026, closing a stake of 4,916 shares — an estimated $738K sold.
111 Capital first reported a position in GH in Q4 2024 and held it in 2 quarters. The position peaked at $738K in Q2 2026. 225 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- 111 Capital reported no remaining Guardant Health position as of Q3 2026 after selling out during the quarter.
- 111 Capital sold 4,916 Guardant Health shares in Q3 2026, an estimated $738K.
- 111 Capital first reported a position in Guardant Health in Q4 2024 and held it in 2 quarters.
- 111 Capital's Guardant Health position peaked at $738K in Q2 2026.
- 225 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.